Trial Profile
A Historical Placebo Controlled Screening Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Fasudil (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 01 Oct 2013 New trial record